Le Lézard
Classified in: Health
Subjects: FDA, PLW, MAT

A New Cannabis Drug Delivery Technology Capable of Meeting FDA Requirement For Delivery of Cannabinoid Formulations in Vapor Form


Enabling Medicaments for: PTSD, Alzheimer's, Chronic pain, Cancer and much more

STILLWATER, Minn., Aug. 29, 2022 /PRNewswire/ -- Vapor Cartridge Technology LLC, based in Stillwater Minnesota, has invented and patented a groundbreaking technology that portends the power to truly change the entire medical cannabis industry. Vapor Cartridge Technology LLC has invented and patented an FDA approvable environmentally friendly cost-effective process, for extracting the essential oils/resins from botanical plants (e.g., cannabis) and an FDA approvable device for delivering a pure and exact dose of the extracted oils/resins as a consistently reliable precise inhalable vapor.

It promises to be, far and away, the most cost-efficient manner to deliver cannabinoid vapors as measured by $/mg/ml of cannabinoids in the bloodstream. It promises to be the only technology that can provide the dose control, formulation control and purity assurance of inhaled botanical vapors required of an FDA approved drug. This technology will result in a paradigm shift in both the Medical and Recreational cannabis markets.

"Once commercialized The Vapor Cartridge Technology will quickly become the medical standard for ingesting cannabinoid drugs in vapor form" according to a spokesperson for the company.

Vapor Cartridge Technology LLC is currently seeking licensing opportunities for their new technology and have launched data rich website (https://vaporcartridgetechnology.com) towards this objective. The compelling website contains a detailed explanation of the science behind the technology, a competitive analysis, the benefits of the technology, the patent portfolio, potential licensees, and a way to contact the company.

Media Contact:

Timothy McCullough
6514912115
[email protected]

SOURCE Vapor Cartridge Technology LLC


These press releases may also interest you

at 01:17
Quarter 1, 2024 - High profitability and strong cash flow Net sales decreased 4.1% to SEK 34,850m (36,352)Organic growth amounted to -4.0%, of which volume accounted for -1.8% and price/mix -2.2%. Excluding restructuring and exited contracts, volumes...

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...



News published on and distributed by: